Nanoparticles for Stem Cell Therapy Bioengineering in Glioma

Frontiers in Bioengineering and Biotechnology

Henry Ruiz-Garcia¹  Alfredo Quinones-Hinojosa¹  Keila Alvarado-Estrada¹  Daniel M. Trifiletti¹  Sunil Krishnan² 

[1] Department of Neurological Surgery, Mayo Clinic, Jacksonville, FL, United States;Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, United States;

关键词: biomaterials;    nanotechnology;    nanoparticles;    stem cells;    glioma;    bioengineering;   

DOI  :  10.3389/fbioe.2020.558375

来源: DOAJ

【 摘 要 】

Gliomas are a dismal disease associated with poor survival and high morbidity. Current standard treatments have reached a therapeutic plateau even after combining maximal safe resection, radiation, and chemotherapy. In this setting, stem cells (SCs) have risen as a promising therapeutic armamentarium, given their intrinsic tumor homing as well as their natural or bioengineered antitumor properties. The interplay between stem cells and other therapeutic approaches such as nanoparticles holds the potential to synergize the advantages from the combined therapeutic strategies. Nanoparticles represent a broad spectrum of synthetic and natural biomaterials that have been proven effective in expanding diagnostic and therapeutic efforts, either used alone or in combination with immune, genetic, or cellular therapies. Stem cells have been bioengineered using these biomaterials to enhance their natural properties as well as to act as their vehicle when anticancer nanoparticles need to be delivered into the tumor microenvironment in a very precise manner. Here, we describe the recent developments of this new paradigm in the treatment of malignant gliomas.

【 授权许可】

Unknown